FEB 20, 2019 2:43 PM PST

Cocktail of Common Antibiotics Fights E. coli Infections

WRITTEN BY: Nouran Amin

Researchers at the Technical University of Denmark are working towards finding new methods for battling antibiotic resistant bacteria. Currently, many disease-causing bacteria retain resistant genes that protect them against antibiotic treatment. One such resistant gene, CTX-M-15, involves encoding the protein--extended spectrum beta-lactamase (ESBL) which leads to resistance in E. coli for urinary tract infections.

Learn more on antibiotic-resistant bacteria:

However, most recently researchers showed that a cocktail of two common antibiotics, mecillinam and cefotaxime, can result in specific multi-resistant E. coli (extended spectrum beta-lactamase, ESBL) sensitive to treatment again. Results of the cocktail antibiotics study was published in Nature and shows that bacteria resistant to mecillinam, were now sensitive to the drug cefotaxime and bacteria that had become resistant to cefotaxime were now sensitive towards mecillinam. These drugs could be administered orally -- as pills, making it easier for doctors to prescribe the already approved drugs to treat multi-drug resistant E. coli (ESBL) infections.

Image Credit: ZMESCIENCE.com

"The results are interesting because we showed that bacteria simply can't survive both drugs. Also, the same gene with only one mutation shows this switch-function. Normally, you will find multiple mutations in multiple resistance genes, controlling different mechanisms," says first-author Carola Rosenkilde, PhD-student at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at Technical University of Denmark (DTU). "We need to take precautionary measures to avoid resistance, because it is very likely that this mutation will occur at some point. By giving both mecillinam and cefotaxime at the same time, the CTX-M-15 mutation works like a switch, and the bacteria become sensitive to treatment again.”

Source: Technical University of Denmark

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
MAY 27, 2021
Neuroscience
Research Less Likely to Be True is Cited More
MAY 27, 2021
Research Less Likely to Be True is Cited More
Researchers from the University of California San Diego have found that non-replicable data is cited 153 times more ofte ...
JUN 09, 2021
Drug Discovery & Development
New Drug Prevents Dementia After Head Injury
JUN 09, 2021
New Drug Prevents Dementia After Head Injury
Researchers led by the University of South Australia have identified a new drug that may be able to help prevent athlete ...
JUN 29, 2021
Microbiology
Gut Fungi May Be an Untapped Reservoir of Antibiotics
JUN 29, 2021
Gut Fungi May Be an Untapped Reservoir of Antibiotics
Viruses are not the only microbes that can cause serious public health problems. Researchers have been warning about a p ...
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
JUL 11, 2021
Drug Discovery & Development
Antibiotic Resistance May Be Passed Between Dogs and Owners
JUL 11, 2021
Antibiotic Resistance May Be Passed Between Dogs and Owners
Household pets may act as a reservoir for mcr-1, a gene that is resistant to a last-resort antibiotic, colistin. The fin ...
JUL 16, 2021
Cardiology
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
JUL 16, 2021
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
When the flow of blood to the heart is blocked, heart cells don't get enough oxygen and begin to die; this is a heart at ...
Loading Comments...